about
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objec...
Read More
25.82
0.95
(3.82%)
2.9M
XNAS Volume
XNAS 22 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..